https://www.selleckchem.com/pr....oducts/pyrrolidinedi
33%, = 0.001), microbiologically documented infections (MDI; 45.24%, = 0.006), resistant infection (11.9%, = 0.013), and mixed infection (21.43%, = 0.003), respectively, than those of the non-ETP cohort. Furthermore, multivariable analysis revealed that T-ALL mixed infection was more likely related to chemotherapy response (OR, 0.025; 95% CI 0.127-0.64; = 0.012) and identified myeloid percentage as a predictor associated with ETP-ALL mixed infection (OR, 0.915; 95% CI 0.843-0.993; = 0.033), with ROC-d
Like
Comment
Share
